News : techtransfer

October 01 2018

Cybersecurity: Leti automates testing

  • Education
  • Industry
  • News
In research conducted under the Catrène-Innovation-Award-winning Mobitrust project, which wrapped up in 2017, Leti automated connected device (smartphone, tablet, etc.) security testing. The automated process enables faster, broader testing and all tests can be carried out in identical conditions.  For the Mobitrust project, the automated testing was used on the TEE* function, which determines the […] >>

June 04 2018

Startup MagIA tackles hepatitis B

  • Industry
  • News
  • Research
MagIA, founded in August 2017 to bring research conducted at G2Elab and LMGP to the market, has just been ranked by Challenges magazine as one of 100 startups to invest in in 2018. The company is developing a portable, ultra-fast immunological test kit. The kit can complete a test—one that would traditionally require drawing blood […] >>

June 04 2018

MRAM: Microelectronics industry adopts spintronics

  • Industry
  • MINATEC
  • News
  • Research
The world’s leading foundries—including Samsung, TSMC, and GlobalFoundries—announced early this year that they would be starting volume manufacturing of MRAM memory, marking a major milestone. Among MRAM’s many benefits: It costs less to manufacture than embedded flash memory, is extremely energy efficient, and offers high communication speeds and a virtually-infinite number of cycles. Spintec’s research […] >>

June 04 2018

Mass fabrication of FD-SOI circuits to begin

  • Industry
  • MINATEC
  • News
  • Research
Leti has been developing FD-SOI, a material that substantially reduces circuit energy consumption, for years. In 2014 the institute signed a partnership with GlobalFoundries, the world’s number-two foundry, to scale the technology up for mass fabrication. This year the partnership reached an important milestone: GlobalFoundries is starting mass fabrication of FD-SOI circuits for the IoT […] >>

June 04 2018

Interview: Thierry Derez, CEO, Covéa “The Clinatec model is unique among biomedical research centers”

  • Industry
  • Interviews
  • News
  • Research
Your company recently began a three-year, €1 million partnership with Clinatec. Why? Our brands have been committed to the disability cause for years. Specifically, we support the prevention and treatment of joint and bone disease, the second-leading cause of disability in France. We hope that our partnership with Clinatec will position us to more effectively […] >>
More information
X